HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 120 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $909,000 | +154.6% | 70,942 | +157.6% | 0.02% | +150.0% |
| Q1 2017 | $357,000 | -42.8% | 27,542 | -56.4% | 0.01% | -33.3% |
| Q4 2016 | $624,000 | +77.8% | 63,184 | +117.7% | 0.02% | +87.5% |
| Q3 2016 | $351,000 | +135.6% | 29,020 | +84.9% | 0.01% | +100.0% |
| Q1 2016 | $149,000 | -18.6% | 15,695 | +48.9% | 0.00% | +33.3% |
| Q4 2015 | $183,000 | -60.7% | 10,539 | -69.6% | 0.00% | -62.5% |
| Q3 2015 | $466,000 | +87.1% | 34,663 | +213.8% | 0.01% | +100.0% |
| Q2 2015 | $249,000 | +4.2% | 11,047 | -58.0% | 0.00% | -20.0% |
| Q3 2014 | $239,000 | -33.1% | 26,282 | -27.3% | 0.01% | -16.7% |
| Q2 2014 | $357,000 | -15.0% | 36,176 | +29.1% | 0.01% | +20.0% |
| Q4 2013 | $420,000 | +63.4% | 28,015 | +20.1% | 0.01% | +66.7% |
| Q3 2013 | $257,000 | – | 23,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |